Nature Communications (Jan 2025)

Immune correlates of early clearance of Mycobacterium tuberculosis among tuberculosis household contacts in Indonesia

  • Todia P. Setiabudiawan,
  • Lika Apriani,
  • Ayesha J. Verrall,
  • Fitria Utami,
  • Marion Schneider,
  • Agnes R. Indrati,
  • Pauline P. Halim,
  • Paulina Kaplonek,
  • Hadar Malca,
  • Jessica Shih-Lu Lee,
  • Simone J. C. F. M. Moorlag,
  • L. Charlotte J. de Bree,
  • Vera P. Mourits,
  • Leo A. B. Joosten,
  • Mihai G. Netea,
  • Bachti Alisjahbana,
  • Ryan P. McNamara,
  • Galit Alter,
  • Arjan van Laarhoven,
  • James E. Ussher,
  • Katrina Sharples,
  • Valerie A. C. M. Koeken,
  • Philip C. Hill,
  • Reinout van Crevel

DOI
https://doi.org/10.1038/s41467-024-55501-6
Journal volume & issue
Vol. 16, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Some individuals, even when heavily exposed to an infectious tuberculosis patient, do not develop a specific T-cell response as measured by interferon-gamma release assay (IGRA). This could be explained by an IFN-γ-independent adaptive immune response, or an effective innate host response clearing Mycobacterium tuberculosis (Mtb) without adaptive immunity. In heavily exposed Indonesian tuberculosis household contacts (n = 1347), a persistently IGRA negative status was associated with presence of a BCG scar, and - especially among those with a BCG scar - with altered innate immune cells dynamics, higher heterologous (Escherichia coli-induced) proinflammatory cytokine production, and higher inflammatory proteins in the IGRA mitogen tube. Neither circulating concentrations of Mtb-specific antibodies nor functional antibody activity associated with IGRA status at baseline or follow-up. In a cohort of adults in a low tuberculosis incidence setting, BCG vaccination induced heterologous innate cytokine production, but only marginally affected Mtb-specific antibody profiles. Our findings suggest that a more efficient host innate immune response, rather than a humoral response, mediates early clearance of Mtb. The protective effect of BCG vaccination against Mtb infection may be linked to innate immune priming, also termed ‘trained immunity’.